Does Prempro cause side effects?
Prempro (conjugated estrogens and medroxyprogesterone) is a combination of female hormones prescribed for women who are experiencing symptoms associated with menopause such as hot flashes, vaginal dryness, vaginal atrophy, and uterine bleeding. Prempro is also used to treat osteoporosis.
Conjugated estrogens are a mixture of several different estrogens (estrogen salts) that are derived from natural sources and blended to approximate the composition of estrogens in the urine of pregnant horses. The main components are sodium estrone sulphate and sodium equilin sulfate.
Estrogens have widespread effects on many tissues in the body. Estrogens cause growth and development of the female sexual organs and maintain female sexual characteristics such as the growth of underarm and pubic hair, body contours, and skeleton. Estrogens also increase secretions from the cervix and growth of the inner lining of the uterus (endometrium).
Medroxyprogesterone is a derivative of progesterone, a naturally occurring female progestin. Progestins are responsible for changes in the mucus and inner lining of the uterus (endometrium) during the second half (secretory phase) of the menstrual cycle.
Progestins prepare the endometrium for implantation of the embryo. Once an embryo implants in the endometrium, for example, and pregnancy occurs, progestins help maintain the pregnancy. At high doses, progestins can prevent ovulation (release of the egg from the ovary) and thereby prevent pregnancy.
Common side effects of Prempro include
- stomach pain,
- fluid accumulation (edema),
- breakthrough bleeding, and
Serious side effects of Prempro include
- an increased risk of heart attacks, stroke, breast cancer, and blood clots in postmenopausal women (50-79 years old), and
- an increased risk of impaired cognition and/or dementia among women over age 65.
Drug interactions of Prempro include St. John's wort, phenobarbital, carbamazepine, and rifampin, because they may increase break-down of estrogens in the liver, reducing blood levels of estrogens and possibly reducing the effect of estrogens.
Erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir, and grapefruit juice may reduce the break-down of estrogens in the liver, increasing blood concentrations of estrogens and possibly increasing side effects of estrogens.
Prempro should not be given to pregnant women due to the risk of harm to the fetus. Estrogens are secreted in breast milk and cause unpredictable effects in the infant. Estrogens should not be taken by women who are breastfeeding.
What are the important side effects of Prempro?
The most common side effects of Prempro and Premphase are:
Other important side effects include:
- breakthrough bleeding, and
The Women's Health Initiative found that postmenopausal women (50-79 years old) taking conjugated estrogens, 0.625 mg daily, in combination with medroxyprogesterone, 2.5 mg daily, for five years, had an increased risk of heart attacks, stroke, breast cancer, and blood clots, while postmenopausal women taking conjugated estrogens without progesterone experienced only increased strokes but not increased blood clots, heart disease, or breast cancer.
There was an increased risk of impaired cognition and/or dementia among women over age 65 treated with either estrogens or estrogens and medroxyprogesterone.
Prempro side effects list for healthcare professionals
The following serious adverse reactions are discussed elsewhere in the labeling:
- Cardiovascular Disorders
- Malignant Neoplasms
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trial of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
In a 1-year clinical trial that included 678 postmenopausal women treated with Prempro and 351 postmenopausal women treated with PREMPHASE, the following adverse reactions occurred at a rate ≥ 1 percent, see Table 1.
TABLE 1: ALL TREATMENT RELATED ADVERSE REACTIONS AT A FREQUENCY ≥ 1 PERCENT
|Body System Adverse event||Prempro 0.625 mg/2.5 mg continuous|
(n = 340)
|Prempro 0.625 mg/5 mg continuous|
(n = 338)
|PREMPHASE 0.625 mg/5 mg sequential|
(n = 351)
|Body As A Whole|
|Abdominal pain||35 (10%)||51 (15%)||58 (17%)|
|Asthenia||13 (4%)||18 (5%)||21 (6%)|
|Back pain||19 (6%)||16 (5%)||23 (7%)|
|Chest pain||5 (1%)||4 (1%)||4 (1%)|
|Flu syndrome||1 ( < 1%)||1 ( < 1%)||4 (1%)|
|Generalized edema||12 (4%)||12 (4%)||8 (2%)|
|Headache||64 (19%)||52 (15%)||66 (19%)|
|Infection||2 ( < 1%)||4 (1)%||0|
|Moniliasis||4 (1%)||3 ( < 1%)||4 (1%)|
|Pain||12 (4%)||14 (4%)||15 (4%)|
|Pelvic pain||11 (3%)||13 (4%)||16 (5%)|
|Hypertension||7 (2%)||7 (2%)||6 (2%)|
|Migraine||6 (2%)||8 (2%)||7 (2%)|
|Palpitation||2 ( < 1%)||3 ( < 1%)||4 (1%)|
|Vasodilatation||2 ( < 1%)||7 (2%)||2 ( < 1%)|
|Diarrhea||4 (1%)||3 ( < 1%)||7 (2%)|
|Dyspepsia||5 (1%)||5 (1%)||7 (2%)|
|Eructation||0||2 ( < 1%)||4 (1%)|
|Flatulence||25 (7%)||27 (8%)||24 (7%)|
|Increased appetite||1 ( < 1%)||5 (1%)||5 (1%)|
|Nausea||26 (8%)||19 (6%)||26 (7%)|
|Metabolic and Nutritional|
|Edema||5 (1%)||6 (2%)||3 ( < 1%)|
|Glucose tolerance decreased||2 ( < 1%)||5 (1%)||4 (1%)|
|Peripheral edema||11 (3%)||10 (3%)||11 (3%)|
|Weight gain||9 (3%)||10 (3%)||11 (3%)|
|Arthralgia||6 (2%)||2 ( < 1%)||7 (2%)|
|Leg cramps||8 (2%)||11 (3%)||12 (3%)|
|Depression||14 (4%)||26 (8%)||29 (8%)|
|Dizziness||9 (3%)||8 (2%)||7 (2%)|
|Emotional lability||5 (1%)||5 (1%)||6 (2%)|
|Hypertonia||4 (1%)||4 (1%)||7 (2%)|
|Insomnia||7 (2%)||6 (2%)||4 (1%)|
|Nervousness||4 (1%)||9 (3%)||6 (2%)|
|Skin and Appendages|
|Acne||1 ( < 1%)||5 (1%)||4 (1%)|
|Alopecia||3 ( < 1%)||4 (1%)||0|
|Dry skin||2 ( < 1%)||3 ( < 1%)||4 (1%)|
|Pruritus||20 (6%)||18 (5%)||13 (4%)|
|Rash||8 (2%)||6 (2%)||7 (2%)|
|Sweating||2 ( < 1%)||4 (1%)||2 ( < 1%)|
|Breast engorgement||5 (1%)||5 (1%)||0|
|Breast enlargement||14 (4%)||14 (4%)||14 (4%)|
|Breast neoplasm||2 ( < 1%)||2 ( < 1%)||4 (1%)|
|Breast pain||110 (32%)||123 (36%)||109 (31%)|
|Cervix disorder||10 (3%)||6 (2%)||10 (3%)|
|Dysmenorrhea||26 (8%)||18 (5%)||44 (13%)|
|Leukorrhea||19 (6%)||13 (4%)||29 (8%)|
|Menstrual disorder||7 (2%)||1 ( < 1%)||5 (1%)|
|Menorrhagia||0||1 ( < 1%)||5 (1%)|
|Metrorrhagia||13 (4%)||5 (1%)||7 (1%)|
|Papanicolaou smear suspicious||5 (1%)||0||8 (2%)|
|Urinary incontinence||4 (1%)||2 ( < 1%)||1 ( < 1%)|
|Uterine spasm||7 (2%)||4 (1%)||7 (2%)|
|Vaginal hemorrhage||5 (1%)||3 ( < 1%)||8 (2%)|
|Vaginal moniliasis||5 (1%)||6 (2%)||7 (2%)|
|Vaginitis||13 (4%)||13 (4%)||10 (3%)|
In addition, phargyngitis and sinusitis were reported as two of the more frequent adverse events ( > 5 percent) in the Prempro clinical study. For pharyngitis, of the 121 events, six events were considered by the investigator causally related to study drug. For sinusitis, of the 73 events, one event was considered as casually related to study drug.
During the first year of a 2-year clinical trial with postmenopausal women between 40 and 65 years of age (88 percent Caucasian), 989 postmenopausal women received continuous regimens of Prempro, and 332 received placebo tablets. Table 2 summarizes adverse reactions that occurred at a rate ≥ 1 percent in at least 1 treatment group.
TABLE 2: ALL TREATMENT RELATED ADVERSE REACTIONS AT A FREQUENCY OF ≥ 1 PERCENT
|Body System Adverse event||Prempro 0.625/2.5 continuous|
|Prempro 0.45/1.5 continuous|
|Prempro 0.3/1.5 continuous|
|Any adverse event||214 (65)||208 (63)||188 (57)||164 (49)|
|Body as a Whole|
|Abdominal pain||38 (11)||33 (10)||24 (7)||21 (6)|
|Asthenia||11 (3)||11 (3)||12 (4)||3 (1)|
|Back pain||12 (4)||12 (4)||8 (2)||4 (1)|
|Chest pain||4 (1)||2 (1)||1 (0)||2 (1)|
|Generalized edema||7 (2)||5 (2)||6 (2)||8 (2)|
|Headache||45 (14)||45 (14)||57 (17)||46 (14)|
|Moniliasis||3 (1)||6 (2)||4 (1)||1 (0)|
|Pain||9 (3)||10 (3)||17 (5)||14 (4)|
|Pelvic pain||9 (3)||7 (2)||5 (2)||4 (1)|
|Hypertension||2 (1)||3 (1)||1 (0)||5 (2)|
|Migraine||11 (3)||8 (2)||5 (2)||3 (1)|
|Palpitation||1 (0)||1 (0)||2 (1)||4 (1)|
|Vasodilatation||0||3 (1)||1 (0)||5 (2)|
|Constipation||5 (2)||7 (2)||6 (2)||3 (1)|
|Diarrhea||5 (2)||2 (1)||6 (2)||8 (2)|
|Dyspepsia||10 (3)||9 (3)||6 (2)||14 (4)|
|Flatulence||16 (5)||18 (5)||13 (4)||8 (2)|
|Increased appetite||6 (2)||2 (1)||0||2 (1)|
|Nausea||13 (4)||13 (4)||16 (5)||16 (5)|
|Metabolic and nutritional|
|Peripheral edema||7 (2)||8 (2)||4 (1)||3 (1)|
|Weight gain||9 (3)||8 (2)||6 (2)||14 (4)|
|Arthralgia||2 (1)||3 (1)||3 (1)||5 (2)|
|Leg cramps||13 (4)||7 (2)||10 (3)||4 (1)|
|Anxiety||5 (2)||4 (1)||1 (0)||4 (1)|
|Depression||23 (7)||11 (3)||11 (3)||17 (5)|
|Dizziness||3 (1)||8 (2)||6 (2)||5 (2)|
|Emotional lability||10 (3)||10 (3)||9 (3)||8 (2)|
|Insomnia||8 (2)||7 (2)||9 (3)||14 (4)|
|Nervousness||6 (2)||3 (1)||4 (1)||6 (2)|
|Skin and Appendages|
|Acne||7 (2)||3 (1)||0||3 (1)|
|Alopecia||1 (0)||6 (2)||4 (1)||2 (1)|
|Pruritus||8 (2)||10 (3)||9 (3)||3 (1)|
|Rash||0||6 (2)||4 (1)||2 (1)|
|Skin discoloration||5 (2)||1 (0)||3 (1)||1 (0)|
|Sweating||3 (1)||1 (0)||0||4 (1)|
|Breast disorder||7 (2)||6 (2)||5 (2)||6 (2)|
|Breast enlargement||18 (5)||9 (3)||5 (2)||3 (1)|
|Breast neoplasm||8 (2)||7 (2)||5 (2)||7 (2)|
|Breast pain||87 (26)||66 (20)||41 (13)||26 (8)|
|Cervix disorder||7 (2)||2 (1)||2 (1)||0|
|Dysmenorrhea||14 (4)||18 (5)||9 (3)||2 (1)|
|Hematuria||4 (1)||3 (1)||1 (0)||2 (1)|
|Leukorrhea||7 (2)||14 (4)||9 (3)||6 (2)|
|Metrorrhagia||7 (2)||14 (4)||4 (1)||1 (0)|
|Urinary tract infection||0||1 (0)||1 (0)||4 (1)|
|Uterine spasm||13 (4)||11 (3)||7 (2)||2 (1)|
|Vaginal dryness||2 (1)||1 (0)||0||6 (2)|
|Vaginal hemorrhage||18 (5)||14 (4)||7 (2)||0|
|Vaginal moniliasis||13 (4)||11 (3)||8 (2)||5 (2)|
|Vaginitis||6 (2)||8 (2)||7 (2)||1 (0)|
In addition, the following events were considered as related to the study drug with an incidence less than 1 percent, including
- accidental injury,
- cough increased,
- sinusitis, and
- upper respiratory infection.
The following adverse reactions have been identified during post-approval use of Prempro or PREMPHASE. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
- Abnormal uterine bleeding,
- dysmenorrhea or pelvic pain,
- increase in size of uterine leiomyomata,
- vaginal candidiasis,
- changes in cervical secretion,
- ovarian cancer,
- endometrial hyperplasia,
- endometrial cancer.
- nipple discharge,
- fibrocystic breast changes,
- breast cancer.
- Deep and superficial venous thrombosis,
- pulmonary embolism,
- superficial thrombophlebitis,
- myocardial infarction,
- increase in blood pressure.
- abdominal pain,
- cholestatic jaundice,
- increased incidence of gallbladder disease,
- changes in appetite,
- ischemic colitis.
- Chloasma or melasma that may persist when drug is discontinued,
- erythema multiforme,
- erythema nodosum,
- loss of scalp hair,
- Retinal vascular thrombosis,
- intolerance of contact lenses.
Central Nervous System
- mental depression,
- exacerbation of chorea,
- mood disturbances,
- exacerbation of epilepsy,
- growth potentiation of benign meningioma.
- Increase or decrease in weight,
- glucose intolerance,
- changes in libido,
- exacerbation of asthma,
- increased triglycerides,
Additional postmarketing adverse reactions have been reported in patients receiving other forms of hormone therapy.
What drugs interact with Prempro?
Data from a single-dose drug-drug interaction study involving conjugated estrogens and medroxyprogesterone acetate indicate that the pharmacokinetic disposition of both drugs is not altered when the drugs are coadministered. No other clinical drug-drug interaction studies have been conducted with CE plus MPA.
- In vitro and in vivo studies have shown that estrogens are metabolized partially by cytochrome P450 3A4 (CYP3A4).
- Therefore, inducers or inhibitors of CYP3A4 may affect estrogen drug metabolism.
- Inducers of CYP3A4, such as St. John's wort (Hypericum perforatum) preparations, phenobarbital, carbamazepine, and rifampin, may reduce plasma concentrations of estrogens, possibly resulting in a decrease in therapeutic effects and/or changes in the uterine bleeding profile.
- Inhibitors of CYP3A4, such as erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice, may increase plasma concentrations of estrogens and may result in side effects.
- Aminoglutethimide administered concomitantly with MPA may significantly depress the bioavailability of MPA.
Prempro (conjugated estrogens and medroxyprogesterone) is a combination of female hormones prescribed for women who are experiencing symptoms associated with menopause such as hot flashes, vaginal dryness, vaginal atrophy, and uterine bleeding. Prempro is also used to treat osteoporosis. Common side effects of Prempro include nausea, vomiting, stomach pain, tenderness, bloating, fluid accumulation (edema), headaches, breakthrough bleeding, and spotting. Prempro should not be given to pregnant women due to the risk of harm to the fetus. Estrogens are secreted in breast milk and cause unpredictable effects in the infant. Estrogens should not be taken by women who are breastfeeding.
Multimedia: Slideshows, Images & Quizzes
Menopause & Perimenopause: Symptoms, Signs
What is menopause? What are the signs of menopause? What age does menopause start? Learn about menopause and perimenopause...
Osteoporosis Super-Foods for Strong Bones With Pictures
What sweetener is loaded with calcium? These bone-building super foods can help stave off osteoporosis, and many of them will...
What Is Osteoporosis? Treatment, Symptoms, Medication
Osteoporosis is a disease characterized by low bone mass and density. Osteoporosis causes symptoms of weak, thin, fragile bones....
Menopause Quiz: Symptoms & Signs
The Menopause Quiz challenges your knowledge about the time in a woman’s life when menstruation ceases. Menopause can bring many...
Osteoporosis Quiz: What is Osteoporosis?
What are the causes, symptoms, and risk factors of osteoporosis? Quiz yourself about vitamin deficiency, maintaining bone...
Picture of Osteoporosis
Thinning of the bones with reduction in bone mass due to depletion of calcium and bone protein. See a picture of Osteoporosis and...
Picture of Osteoporosis Progression
Bone mass (bone density) is the amount of bone present in the skeletal structure. See a picture of Osteoporosis Progression and...
9 Signs of Perimenopause
Perimenopause occurs before menopause as estrogen levels begin to change. This can cause menopause like symptoms such as hot...
Osteoporosis: Simple Steps to Boost Bone Health
Your bones tend to weaken as you age. But it's not unavoidable. Here are things you can do to keep them as strong as possible.
Women's Health: 10 Tips to Ease Menopause Symptoms
What happens during menopause? At what age do menopause symptoms start? Women in their 40s or 50s may begin to have hot flashes,...
Related Disease Conditions
Menopause is the time in a woman's life when menstrual periods permanently stop, also called the "change of life." Menopause symptoms and signs include hot flashes, night sweats, irregular vaginal bleeding, vaginal dryness, painful intercourse, urinary incontinence, weight gain, and emotional symptoms such as mood swings. Treatment of menopausal symptoms varies and should be discussed with your physician.
Sex and Menopause
Perimenopause is the time in a woman's life when she is approaching menopause. During this time a woman starts to develop symptoms of declining estrogen levels that may include mood swings, painful sex, night sweats, hot flashes, and weight gain. Every adult woman eventually will experience perimenopause.
Learn about osteoporosis, a condition characterized by the loss of bone density, which leads to an increased risk of bone fracture. Unless one experiences a fracture, a person may have osteoporosis for decades without knowing it. Treatment for osteoporosis may involve medications that stop bone loss and increase bone strength and bone formation, as well as quitting smoking, regular exercise, cutting back on alcohol intake, and eating a calcium- and vitamin D-rich balanced diet.
Osteoarthritis vs. Osteoporosis Differences and Similarities
Arthritis is defined as painful inflammation and joint stiffness. Osteoarthritis is a type of arthritis and the most common cause of chronic joint pain, affecting over 25 million Americans. Osteoarthritis is a type of arthritis that involves the entire joint. Osteoporosis is not a type of arthritis. It is a disease that mainly is caused by a loss of bone tissue that is not limited to the joint areas. It is possible for one person to have both osteoarthritis and osteoporosis. The differences in the signs and symptoms of osteoarthritis and osteoporosis include; pain, stiffness, and joint swelling, joint deformity, crackle sounds when the joint is moving, and walking with a limp. Osteoporosis is called the "silent disease" because it can progress for years without signs and symptoms before it is diagnosed, severe back pain, bone fractures, height loss, and difficulty or inability to walk. The differences in the causes of osteoarthritis and osteoporosis are that osteoarthritis usually is caused by wear and tear on the joints. Osteoporosis usually is caused by one or more underlying problems, for example, calcium and vitamin D deficiencies. Treatment for osteoarthritis and osteoporosis are not the same. There is no cure for osteoarthritis or osteoporosis.
Premature menopause is when menopause occurs in a woman before the age of 40. Causes of premature menopause include premature ovarian failure, treatments for cancer and other conditions, surgical removal of the ovaries, chronic diseases of the pituitary or thyroid gland, or psychiatric disorders. Treatment is directed at menopausal symptoms.
What Are the 40 Symptoms of Menopause?
Menopause is the end of the reproductive era of a woman's life that is characterized by drastic changes in her emotional and physical aspects. Studies have identified around 40 signs and symptoms of menopause, but not every woman gets all of them.
Male menopause refers to the decline in testosterone production in men. As men age, they often experience many of the same symptoms that women experience in menopause. Testosterone replacement therapy may relieve some of these symptoms.
Sex and Menopause
Menopause is often associated with a change in sexual functioning. Loss of estrogen, bladder control issues, anxiety, stress, health concerns, medications, and sleep disturbances often result in a decrease in libido. Though there are currently no good drugs for treating sexual problems in women, there are ways to increase intimacy with a partner and treat vaginal dryness.
15 Things Women Should Know About Menopause
Menopause is a phase in a woman's life that challenges her physically and emotionally. Many women deal with menopause without any medical treatments, whereas some women with severe symptoms require therapies.
Sexual Side Effects of Menopause
Menopause marks the end of the reproductive era in a woman's life. Some women view it positively as periods no longer trouble them and there is no chance of getting pregnant even with unprotected sex. However, as estrogen and testosterone levels take a plunge during menopause, some women experience the sexual side effects of menopause.
Treatment & Diagnosis
- Menopause: Making it the Best Years of Your Life
- Menopause and Perimenopause, A Woman's Guide to
- Male Menopause
- Menopause: The Men's Guide to Understanding It
- Menopause: Super Nutrition for Menopause
- Osteoporosis: Stopping Before it Starts
- Menopause: A New Perspective
- Menopause: Taking Charge
- Menopause Made Easy with Carolle Jean-Murat
- Menopause: Change of Life, Change of Diet
- Menopause FAQs
- Osteoporosis FAQs
- Thyroid Disease and Menopause
- Thyroid Disease, Osteoporosis and Calcium
- The Women's Health Initiative in Perspective: The Last Straw for Estrogen Therapy?
- Osteoporosis Linked to Bone Gene
- Osteoporosis - Bone Up On Estrogen...Women's Health
- Osteoporosis Prevention & Treatment - Medications, Fluoride, Monitoring
- Menopause: Home Menopause Test Kits, Are They Worth It?
- Hot Flashes: Anxiety Worsens Hot Flashes
- Can Synthroid Taken for Hypothyroidism Cause Osteoporosis?
- Can Menopause Cause High Cholesterol?
- How Is Menopause Diagnosed After a Hysterectomy?
- How Does Menopause Affect Polycystic Ovarian Syndrome (PCOS)?
- Does Vaginal Moisture Change During Perimenopause?
- Do Soy Isoflavones Treat Menopause Hot Flashes?
- How Do You Treat a Spine Fracture from Osteoporosis?
- Can You Go Through Menopause at 40?
- Does Perimenopause Cause Mood Swings?
- Does Menopause Cause Pain During Sex?
- Does Menopause Affect Memory?
- What Are the Best Exercises for Osteoporosis?
- Are Night Sweats a Sign of Menopause?
- Can Soy Help Menopause Symptoms?
- Do I Need Birth Control After Menopause?
- Does Menopause Cause High Blood Pressure?
- Do You Get More UTIs During Menopause?
- How Can You Prevent Osteoporosis?
- What Food Can I Eat to Prevent Osteoporosis?
- Can You Still Get Menopause After Hysterectomy?
- Do All Women Get Menopause?
- Does Hashimoto's Affect Heart Disease and Osteoporosis?
- Male Menopause
- Menopause: 10 Questions To Ask Your Doctor
- Menopause Symptoms
- Ask the Experts - Menopause
- Menopause: Change of Life, Change of Diet
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.